SC
IDYA icon

Stempoint Capital’s IDEAYA Biosciences IDYA Stock Holding History

Stempoint Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-161,659
Closed -$5.59M – 98
2025
Q4 		$5.59M Sell
161,659
-210,166
-57% -$6.7M 0.96% 35
2025
Q3 		$10.1M Buy
371,825
+205,940
+124% +$4.98M 2.04% 12
2025
Q2 		$3.49M Buy
165,885
+98,886
+148% +$1.9M 1.12% 27
2025
Q1 		$1.1M Buy
+66,999
New +$1.43M 0.35% 42
2024
Q4 		– Sell
-132,703
Closed -$4.2M – 67
2024
Q3 		$4.2M Buy
132,703
+30,916
+30% +$1.17M 1.26% 26
2024
Q2 		$3.57M Buy
101,787
+14,394
+16% +$570K 1.05% 30
2024
Q1 		$3.83M Buy
+87,393
New +$3.76M 1.02% 29

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return